Table 3.
Standardized Incidence Ratio (SIR) by specific site for cancer 1985–2011 among Swedish seafarers, men and women
| ICD-7 | Cancer | Men | Women | ||
|---|---|---|---|---|---|
| Obs | SIR (95% CI) | Obs | SIR (95% CI) | ||
| 140 | Lip | 17 | 1.63 (0.86–2.50) | ≤ 3 | |
| ≥ 5 years cumulative sea service | 16 | 1.96 (1.10–2.94) | |||
| 141 | Tongue | 20 | 1.25 (0.75–1.81) | ≤ 3 | |
| 143–148 | Mouth, pharynx | 76 | 1.66 (1.29–2.05) | 4 | 0.56 (0.14–1.12) |
| ≥ 5 years cumulative sea service | 66 | 2.02 (1.56–2.51) | |||
| 150 | Oesophagus | 54 | 1.52 (1.13–1.94) | < 3 | |
| ≥ 5 years cumulative sea service | 45 | 1.64 (1.17–2.15) | |||
| 151 | Stomach | 78 | 1.14 (0.89–1.40) | 12 | 0.95 (0.48–1.51) |
| 153 | Colon | 193 | 1.01 (0.87–1.15) | 50 | 0.91 (0.68–1.17) |
| 154 | Rectum | 141 | 1.06 (0.89–1.25) | 26 | 0.87 (0.57–1.20) |
| 155.0 | Liver | 34 | 1.04 (0.70–1.41) | ≤ 3 | |
| 155.1–9 | Gallbladder | 14 | 0.80 (0.40–1.25) | ≤ 3 | |
| 157 | Pancreas | 52 | 0.87 (0.64–1.12) | 15 | 1.00 (0.53–1.53) |
| 160 | Nasal cavity | 6 | 1.07 (0.36–1.95) | ≤ 3 | |
| 161 | Larynx | 44 | 1.98 (1.40–2.57) | 4 | 3.10 (0.78–6.20) |
| ≥ 5 years cumulative sea service | 38 | 2.21 (1.51–2.97) | |||
| 162.1 | Lung | 341 | 1.51 (1.35–1.67) | 84 | 1.54 (1.23–1.87) |
| ≥ 5 years cumulative sea service | 183 | 1.61 (1.43–1.80) | 43 | 1.61 (1.16–2.10) | |
| 162.2 | Pleura (mesothelioma) | 16 | 1.29 (0.73–1.93) | ||
| 170 | Breast | 291 | 0.74 (0.65–0.82) | ||
| 171 | Cervix uteri | 49 | 0.96 (0.71–1.24) | ||
| 172 | Uterus | 27 | 0.58 (0.36–0.81) | ||
| 175 | Ovaries | 46 | 1.02 (0.73–1.32) | ||
| 177 | Prostate | 812 | 0.92 (0.86–0.98) | ||
| 178 | Testis | 77 | 1.02 (0.79–1.26) | ||
| 179 | Male genitals | 10 | 0.90 (0.36–1.54) | ||
| 180 | Kidney | 79 | 0.86 (0.68–1.06) | 18 | 1.10 (0.61–1.65) |
| 181 | Urinary bladder | 218 | 1.17 (1.02–1.33) | 12 | 0.70 (0.35–1.11) |
| ≥ 5 years cumulative sea service | 183 | 1.26 (1.08–1.44) | 8 | 0.91 (0.34–1.58) | |
| 190 | Malignant melanoma | 176 | 1.04 (0.88–1.19) | 75 | 0.90 (0.71–1.10) |
| 191 | Other skin | 177 | 1.12 (0.95–1.29) | 22 | 0.71 (0.42–1.04) |
| 193 | Brain | 107 | 0.95 (0.77–1.13) | 48 | 0.93 (0.68–1.20) |
| 194–195 | Thyroid | 48 | 0.76 (0.55–0.98) | 35 | 0.62 (0.43–0.83) |
| 196 | Bone | 7 | 1.09 (0.31–2.03) | ≤ 3 | |
| 197 | Connective tissue | 24 | 1.00 (0.63–1.42) | 4 | 0.52 (0.13–1.04) |
| 199 | Other | 91 | 1.18 (0.95–1.43) | 20 | 0.78 (0.47–1.13) |
| 200, 202 | Non-Hodgkin’s lymphoma | 108 | 0.93 (0.75–1.11) | 25 | 0.91 (0.58–1.27) |
| 201 | Hodgkin’s disease | 16 | 0.78 (0.44–1.17) | 8 | 0.96 (0.36–1.68) |
| 203 | Multiple myeloma | 32 | 0.82 (0.54–1.13) | 8 | 0.98 (0.37–1.72) |
| 204–209 | Leukaemia | 105 | 1.01 (0.82–1.22) | 18 | 0.65 (0.36–0.98) |
| 140–209 | All sites | 3221 | 1.05 (1.01–1.09) | 938 | 0.83 (0.78–0.89) |
| ≥ 5 years cumulative sea service | 2491 | 1.10 (1.06–1.15) | 357 | 0.82 (0.73–0.90) | |
Obs observed cases; CI confidence interval